Pharma-Bio Serv, Inc. last reported quarterly results on Sep 14, 2026, for Q3 FY2026 (the quarter ended Jul 31, 2026): revenue of $2.3 million (+19.0% year over year) and diluted EPS of -$0.00. It usually reports 45–46 days after a quarter ends. Based on that pattern, the next release is estimated for around Dec 16, 2026.
Results for Q4 FY2026, the quarter ending around Oct 31, 2026. Expected on a Wednesday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 45–46 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Sep 14, 2026
45 days after quarter end
|
Q3 FY2026
ended Jul 31, 2026
|
2
+19.0%
|
-0
+93.0%
|
-0.00
+88.9%
|
|
Jun 15, 2026
46 days after quarter end
|
Q2 FY2026
ended Apr 30, 2026
|
3
+11.8%
|
0
+144.3%
|
0.01
+150.0%
|
|
Mar 17, 2026
45 days after quarter end
|
Q1 FY2026
ended Jan 31, 2026
|
2
-7.1%
|
0
+285.0%
|
0.00
|
|
Sep 15, 2025
46 days after quarter end
|
Q3 FY2025
ended Jul 31, 2025
|
2
-18.8%
|
-0
+33.9%
|
-0.01
+33.2%
|
|
Jun 16, 2025
47 days after quarter end
|
Q2 FY2025
ended Apr 30, 2025
|
2
+1.7%
|
0
+144.6%
|
0.00
+143.0%
|
|
Mar 17, 2025
45 days after quarter end
|
Q1 FY2025
ended Jan 31, 2025
|
2
+3.8%
|
0
+103.2%
|
0.00
+100.0%
|
|
Sep 16, 2024
47 days after quarter end
|
—
ended Jul 31, 2024
|
—
|
—
|
—
|
|
Jun 14, 2024
45 days after quarter end
|
—
ended Apr 30, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- PBSV (OTC)
- Fiscal year ends
- October 31
- Headquarters
- Dorado, PR
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1304161
- Former names
- LAWRENCE CONSULTING GROUP INC (until Feb 28, 2006)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- Astrana Health, Inc. ASTH
- ICF International, Inc. ICFI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.